On May 2, 2023 Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, reported that six data presentations, including two oral presentations, highlighting the Company’s preclinical gene therapy programs and platforms will be presented at the American Society of Gene and Cell Therapy (ASGCT) (Free ASGCT Whitepaper) 26th Annual Meeting, being held at the Los Angeles Convention Center in Los Angeles and virtually on May 16-20, 2023 (Press release, Poseida Therapeutics, MAY 2, 2023, View Source [SID1234630862]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oral Presentations:

Title: Preclinical Proof-of-Concept: A Novel Hybrid Gene Therapy Approach to Treat Severe Early-Onset Ornithine Transcarbamylase Deficiency
Session Title: Metabolic, Storage, Endocrine, Liver and Gastrointestinal Diseases I
Presentation Time: Thursday, May 18, 2023, 2:30 – 2:45 PM PST
Location: Room 403 AB
Abstract Number: 127

Title: Cas-CLOVER Technology Enables Precise Gene Editing and Site-Specific Transgene Insertion in Mouse Liver
Session Title: Gene Targeting and Gene Correction: Liver
Presentation Time: Thursday, May 18, 2023 3:00 – 3:15 PM PST
Location: Room 515 AB
Abstract Number: 157

Poster Presentations:

Title: Demonstration of Human Factor VIII Expression and Activity Following Single and Repeat Dosing of a Non-Viral Integrating Gene Therapy
Session Title: Wednesday Poster Session
Session Date/Time: Wednesday, May 17, 2023, 12:00 PM PST
Location: West Hall A
Abstract & Poster Board Number: 638

Title: Development of a Novel Non-Viral Gene Therapy Platform
Session Title: Thursday Poster Session
Session Date/Time: Thursday, May 18, 2023, 12:00 PM PST
Location: West Hall A
Abstract & Poster Board Number: 945

Title: Editing of a γ-Globin (HBG1/HBG2) cis-Regulatory Element in Human Hematopoietic Stem and Progenitor Cells Using Cas-CLOVER Technology Reactivates Fetal Hemoglobin
Session Title: Thursday Poster Session
Session Date/Time: Thursday, May 18, 2023, 12:00 PM PST
Location: West Hall A
Abstract & Poster Board Number: 1212

Title: Development and Optimization of Novel Super piggyBac-Based Hybrid Gene Therapy Approach
Session Title: Friday Poster Session
Session Date/Time: Friday, May 19, 2023, 12:00 PM PST
Location: West Hall A
Abstract & Poster Board Number: 1318